HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peg-asparaginase for acute lymphoblastic leukemia.

AbstractIMPORTANCE OF THE FIELD:
Asparaginase is a prominent component of pediatric and adolescent treatment for acute lymphoblastic leukemia. These treatment regimens are now being employed in adults. Knowledge of the efficacy and toxicity of asparaginase preparations is essential when using these treatments. AREAS COVERED BY THIS REVIEW: The search terms used were asparaginase, leukemia, pegylated, oncaspar, adolescent and young adult. Literature was searched in Pubmed/Medline with no limitations on year of publication. Abstracts from the American Society of Hematology meetings and the American Society of Clinical Oncology were searched from 2004 - 2008 using the same terms.
WHAT THE READER WILL GAIN:
The reader will gain knowledge of the tolerability and efficacy of pegylated asparaginase when treating acute lymphoblastic leukemia.
TAKE HOME MESSAGE:
Pegylated asparaginase is generally well tolerated in adult patients with efficacy that appears to be at least equivalent to native asparaginase preparations.
AuthorsMichael Rytting
JournalExpert opinion on biological therapy (Expert Opin Biol Ther) Vol. 10 Issue 5 Pg. 833-9 (May 2010) ISSN: 1744-7682 [Electronic] England
PMID20345338 (Publication Type: Journal Article, Review)
Chemical References
  • Antineoplastic Agents
  • Polyethylene Glycols
  • pegaspargase
  • Asparaginase
Topics
  • Adolescent
  • Adult
  • Antineoplastic Agents (adverse effects, therapeutic use)
  • Asparaginase (adverse effects, therapeutic use)
  • Drug Hypersensitivity (etiology)
  • Humans
  • Polyethylene Glycols (adverse effects, therapeutic use)
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (drug therapy)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: